Hi anil, you should visit Dept. of Medical ophthalmology, Retina & Uvea (AIIMS)
As far as central serus retinopathy is concerned, Differential diagnosis should be immediately performed to rule out retinal detachment, which is a medical emergency. Additionally, a clinical record should be taken to keep a timeline of the detachment. Most eyes with CSR undergo spontaneous resorption of subretinal fluid within 3–4 months, recovery of visual acuity usually follows. Any ongoing corticosteroid treatment should be tapered and stopped, where possible. It is important to check current medication, including nasal sprays and creams, for ingredients of corticosteroids, if found seek advice from a medical practitioner for an alternative. Patients sometimes present with an obvious history of psychosocial stress, in which case counselling and expectancy is relevant. Treatment should be considered if it does not disappear within 3–4 months, spontaneously or as the result of counselling. Laser photocoagulation, which effectively burns the leak area shut, may be considered in cases where there is little improvement in a 3 to 4 month duration, and the leakage is confined to a single or a few sources of leakage at a safe distance from the fovea. However, for many cases the leak is very near the central macula, where photocoagulation would leave a blind spot or the leakage is widespread and its source is difficult to identify. Foveal attenuation has been associated with more than 4 months' duration of symptoms, however a better long-term outcome has not been demonstrated with laser photocoagulation than without photocoagulation. Laser photocoagulation can permanently damage vision where applied. Carefully tuned lasers can limit this damage. Even so laser photocoagulation is not a preferred treatment for leaks in the central vision and is considered an outdated treatment by some doctors. In chronic case Transpupillary thermotherapy has been suggested as an alternative to laser photocoagulation where the leak is in the central macula. Photodynamic therapy (PDT) with verteporfin has shown promise as an effective treatment with minimal complications. Follow up studies have confirmed the treatment's long-term effectiveness including its effectiveness for the chronic variant of the disease. Indocyanine green angiography can be used to predict how the patient will respond to PDT. Yellow micropulse laser has shown promise in very limited trials. Other experimental treatments include anti-VEGFs and several oral medications. Warm regards, Yogesh Chhabra On 9/19/14, Anil Kumar <anil4aifrie...@gmail.com> wrote: > Dear List, > > One of my colleagues is suffering from Resolved Central Serous > Retinapthy. It is there in both the eyes. Blocked Flurosence in > macular area of right eye and fluid accumalation is observe in both > the eyes. Focal laser treatment was done in both the eyes. Evastin > and Lucentus injections were given in the right eye. Present status > is , vision is almost nil in the right eye and very dull in left eye . > The question is whether CSR is curable? if, either in Ayurveda or in > Allopathy treatment is advisable? > > Your quick response in this regard would be highly appreciated. > > Thanks in anticipation, > > (Anilkumar K.R.) > Email: anilhi...@gmail.com / anilkuma...@ntpc.co.in > > > > Register at the dedicated AccessIndia list for discussing accessibility of > mobile phones / Tabs on: > http://mail.accessindia.org.in/mailman/listinfo/mobile.accessindia_accessindia.org.in > > > Search for old postings at: > http://www.mail-archive.com/accessindia@accessindia.org.in/ > > To unsubscribe send a message to > accessindia-requ...@accessindia.org.in > with the subject unsubscribe. > > To change your subscription to digest mode or make any other changes, please > visit the list home page at > http://accessindia.org.in/mailman/listinfo/accessindia_accessindia.org.in > > > Disclaimer: > 1. Contents of the mails, factual, or otherwise, reflect the thinking of the > person sending the mail and AI in no way relates itself to its veracity; > > 2. AI cannot be held liable for any commission/omission based on the mails > sent through this mailing list.. > Register at the dedicated AccessIndia list for discussing accessibility of mobile phones / Tabs on: http://mail.accessindia.org.in/mailman/listinfo/mobile.accessindia_accessindia.org.in Search for old postings at: http://www.mail-archive.com/accessindia@accessindia.org.in/ To unsubscribe send a message to accessindia-requ...@accessindia.org.in with the subject unsubscribe. To change your subscription to digest mode or make any other changes, please visit the list home page at http://accessindia.org.in/mailman/listinfo/accessindia_accessindia.org.in Disclaimer: 1. Contents of the mails, factual, or otherwise, reflect the thinking of the person sending the mail and AI in no way relates itself to its veracity; 2. AI cannot be held liable for any commission/omission based on the mails sent through this mailing list..